Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
78.47
+1.90 (2.47%)
Nov 18, 2026, 12:51 PM EST - Market open
Disc Medicine Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Disc Medicine stock has a consensus rating of "Strong Buy" and an average price target of $127.69. The average 1-year stock price forecast is 62.73% higher than the current stock price, while the lowest is $104 (+32.54%) and the highest is $170 (+116.66%).
Price Target: $127.69 (+62.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $92 → $104 | Buy | Reiterates | $92 → $104 | +32.54% | Nov 18, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $120 | Buy | Maintains | $120 | +52.93% | Nov 10, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $132 | Buy | Initiates | $132 | +68.23% | Nov 9, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $115 | Buy | Maintains | $115 | +46.56% | Nov 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 → $127 | Buy | Reiterates | $120 → $127 | +61.86% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
43.54M
EPS This Year
-6.11
from -6.01
EPS Next Year
-6.18
from -6.11
EPS and Forward PE are based on non-GAAP adjusted numbers.